{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:19:48Z","timestamp":1778865588588,"version":"3.51.4"},"reference-count":17,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2017,12,22]],"date-time":"2017-12-22T00:00:00Z","timestamp":1513900800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-74720"],"award-info":[{"award-number":["MOP-74720"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000226","name":"Ontario Ministry of Health and Long-Term Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0189966","type":"journal-article","created":{"date-parts":[[2017,12,22]],"date-time":"2017-12-22T18:52:00Z","timestamp":1513968720000},"page":"e0189966","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Determinants of magnesium sulphate use in women hospitalized at &lt;29 weeks with severe or non-severe pre-eclampsia"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6558-2716","authenticated-orcid":true,"given":"Dane A.","family":"De Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lily","family":"Proctor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"von Dadelszen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghan","family":"McCoach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the Canadian Perinatal Network (CPN) Collaborative Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1355-610X","authenticated-orcid":true,"given":"Laura A.","family":"Magee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,12,22]]},"reference":[{"issue":"8963","key":"ref1","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/S0140-6736(95)91034-4","article-title":"Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial","volume":"345","year":"1995","journal-title":"Lancet"},{"issue":"9321","key":"ref2","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/S0140-6736(02)08778-0","article-title":"Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial","volume":"359","author":"D Altman","year":"2002","journal-title":"Lancet"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1471-0528.2005.00785.x","article-title":"Cost-effectiveness of prophylactic magnesium sulphate for 9996 women with pre-eclampsia from 33 countries: economic evaluation of the Magpie Trial","volume":"113","author":"J Simon","year":"2006","journal-title":"BJOG"},{"key":"ref4","unstructured":"World Health Organization. WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia. 2011. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/apps.who.int\/iris\/bitstream\/10665\/44703\/1\/9789241548335_eng.pdf\" xlink:type=\"simple\">apps.who.int\/iris\/bitstream\/10665\/44703\/1\/9789241548335_eng.pdf<\/ext-link>."},{"issue":"12","key":"ref5","doi-asserted-by":"crossref","first-page":"e113715","DOI":"10.1371\/journal.pone.0113715","article-title":"Hypertensive disorders of pregnancy: a systematic review of international clinical practice guidelines","volume":"9","author":"TE Gillon","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"ref6","first-page":"715","article-title":"Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy","volume":"157","author":"ME Helewa","year":"1997","journal-title":"CMAJ"},{"issue":"7","key":"ref7","first-page":"907","article-title":"Report of the Canadian Hypertension Society Consensus Conference: 2. Nonpharmacologic management and prevention of hypertensive disorders in pregnancy","volume":"157","author":"JM Moutquin","year":"1997","journal-title":"CMAJ"},{"issue":"9","key":"ref8","first-page":"1245","article-title":"Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy","volume":"157","author":"E Rey","year":"1997","journal-title":"CMAJ"},{"issue":"3 Suppl","key":"ref9","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1701-2163(16)32776-1","article-title":"Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy","volume":"30","author":"LA Magee","year":"2008","journal-title":"J Obstet Gynaecol Can"},{"issue":"7","key":"ref10","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1701-2163(15)30532-6","article-title":"Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary","volume":"36","author":"LA Magee","year":"2014","journal-title":"J Obstet Gynaecol Can"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.preghy.2014.01.003","article-title":"Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy","volume":"4","author":"LA Magee","year":"2014","journal-title":"Pregnancy Hypertens"},{"issue":"9761","key":"ref12","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(10)61351-7","article-title":"Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model","volume":"377","author":"P von Dadelszen","year":"2011","journal-title":"Lancet"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1701-2163(16)34795-8","article-title":"The Canadian Perinatal Network: a national network focused on threatened preterm birth at 22 to 28 weeks&apos; gestation","volume":"33","author":"LA Magee","year":"2011","journal-title":"J Obstet Gynaecol Can"},{"key":"ref14","first-page":"56","article-title":"Encycolpedia of Epidemiology","volume":"2","author":"H Morgenstern","year":"2008"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2105\/AJPH.88.1.15","article-title":"Use and misuse of population attributable fractions","volume":"88","author":"B Rockhill","year":"1998","journal-title":"Am J Public Health"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/1753495X13518319","article-title":"Magnesium sulphate for eclampsia prevention: Quality of care evaluation in a tertiary centre in Qu\u00e9bec, Canada","volume":"7","author":"P Girard","year":"2014","journal-title":"Obstetric Medicine: The Medicine of Pregnancy"},{"issue":"11","key":"ref17","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S1701-2163(16)30047-0","article-title":"Magnesium Sulphate for Eclampsia and Fetal Neuroprotection: A Comparative Analysis of Protocols Across Canadian Tertiary Perinatal Centres","volume":"37","author":"DA De Silva","year":"2015","journal-title":"J Obstet Gynaecol Can"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0189966","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T01:06:30Z","timestamp":1588986390000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0189966"}},"subtitle":[],"editor":[{"given":"Stefan","family":"Gebhardt","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,12,22]]},"references-count":17,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,12,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0189966","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,22]]}}}